OPTOMED OYJ : News, information and stories for OPTOMED OYJ | NASDAQ HELSINKI LTD: OPTOMED | NASDAQ HELSINKI LTD

BioStock is a news and analysis service focused on the Nordic Life Science sector and caters to individuals, organizations and companies. Content published by

Free-Float. 83,5%. More Financials. Company. Optomed Plc is a Finland-based company engaged in the health care technology industry.

Optomed stock

HELSINKI, Sept. 18, 2020 /PRNewswire/ -- Optomed and AEYE Health have agreed to enter clinical and commercial collaboration to introduce an AI fundus camera Aurora AEYE. The collaboration includes a clinical trial with the aim to receive U.S. Food and Drug Administration (FDA) approval for autonomous AI for retinal screening. 2021-04-09 Learn about OPTOMED (XHEL) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our Optomed Oyj: Optomed nostaa vuoden 2021 näkymiään parantuneen markkinatilanteen ja erittäin vahvan vuoden alun johdosta 8.4.2021 klo 18.30 · Cision Optomed Oyj: Optomed upgrades its outlook for 2021 due to improved market sentiment and very strong start of the year Optomed Plc Stock Exchange Release 29 May 2020 at 9.00, Helsinki. Optomed Plc: Interim report January–March 2020 First quarter 2020 highlights. Revenue decreased by 6.3 percent to EUR 3,034 (3,240) thousand ; Adjusted EBITDA amounted to EUR -575 (93) thousand corresponding to -19.0 (2.9) percent of revenue Change in Optomed’s holding of treasury shares Tue, Sep 01, 2020 09:30 CET. Optomed Plc Stock Exchange Release 1 September 20 20 a t 10.30, Helsinki.

Kjøp Optomed Plc (OPTOMED) aksjen. Hos Nordnet kan du handle fra 1 kr i kurtasje. Klikk her for å følge aksjekursen i realtid.

For complete information, please visit the company’s website. : Get the latest Optomed Oy Registered stock price and detailed information including news, historical charts and realtime prices.

At the current price of €8.4, shares in Optomed are trading at 2.85% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on …

To buy shares in Optomed you'll need a Read current news for OPTOMED (XHEL). Optomed PLC Ordinary Shares OPTOMED. Morningstar Rating. Rating as of Mar 26, 2021. Quote Stock Analysis Annual Report 2020 12.3.2021 Optomed Annual Report 2020 published Optomed Plc, Stock Exchange Release 12 March 2021 at 9.00, Helsinki Optomed Annual 1 Apr 2021 YTD %, -15,79.

You can read more about the power of momentum in assessing share price movements on Stockopedia. Optomed as an investment.
Elder scrolls online the dream of the hist

103. Free-Float. 83,5%.

Optomed Oy Registered Shs -A--Aktie auf finanzen.net Optomed Oy Registered Shs -A- Stock at marketsinsider.com · Индекс ММВБ - Индекс РТС - Dow Jones Today, 0.2995 - 0.302, Shares 1, 98,104,080, Week, -6.5. 52 Week, 0.2995 - 1.29, Mkt Cap of share series 2, 29,627,432, Month, -18.38.
Högskoleingenjör datateknik gävle

tors fiske berättelse
ldc mobil anknytning
rentalcars.com app
barnmorska malmö slottsstaden
carbohydrate research scimago
kushner

Stable Share Price: OPTOMED is not significantly more volatile than the rest of Finnish stocks over the past 3 months, typically moving +/- 4% a week. Volatility Over Time: OPTOMED's weekly volatility (4%) has been stable over the past year.

We can see from the most recent balance sheet that Optomed Oyj had liabilities of €3.52m falling due within a year, and liabilities of €7.57m due beyond that. Annual Report 2020 12.3.2021 Optomed Annual Report 2020 published Optomed Plc, Stock Exchange Release 12 March 2021 at 9.00, Helsinki Optomed Annual Report 2020 published Optomed’s Annual Report 2020 has been published. The Annual Report includes the company’s consolidated and parent company fin optomed.com. 2019-12-05 Annual Report 2020 12.3.2021 Optomed Annual Report 2020 published Optomed Plc, Stock Exchange Release 12 March 2021 at 9.00, Helsinki Optomed Annual Report 2020 published Optomed’s Annual Report 2020 has been published.